Search PubMed⌕ Search
Home/Archive/PubMed

PubMed · 9916496

[Zolmitriptan].

G Monseu·J Sternon
View original source ↗Export metadata ↓

Abstract

One of the outstanding therapeutic revolutions of this last decade has been the introduction of selective serotonin agonists in the acute treatment of migraine. After sumatriptan, introduced in Belgium in 1992, other "triptans" are emerging. The efficacy and the pharmacoeconomic profile of zolmitriptan, the second "triptan" now available in Belgium, are reviewed and the arrival of a third triptan, naratriptan is announced.

Explore related subjects

Chemistry, PharmaceuticalHumansIndolesMigraine DisordersOxazolesOxazolidinonesPiperidinesSerotonin Receptor AgonistsSumatriptanTryptaminesJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

G Monseu, J Sternon. 1998. [Zolmitriptan].. https://pubmed.ncbi.nlm.nih.gov/9916496/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2000

Drug discovery: a historical perspective.

Driven by chemistry but increasingly guided by pharmacology and the clinical sciences, drug research has contributed more to the progress of medicine during the past century than any other scientific factor. The advent of molecular biology and, in particular, of genomic sciences is having a deep impact on drug discovery. Recombinant proteins and monoclonal antibodies have greatly enriched our therapeutic armamentarium. Genome sciences, combined with bioinformatic tools, allow us to dissect the genetic basis of multifactorial diseases and to determine the most suitable points of attack for future medicines, thereby increasing the number of treatment options. The dramatic increase in the complexity of drug research is enforcing changes in the institutional basis of this interdisciplinary endeavor. The biotech industry is establishing itself as the discovery arm of the pharmaceutical industry. In bridging the gap between academia and large pharmaceutical companies, the biotech firms have been effective instruments of technology transfer.

Chemistry, Pharmaceutical↗